Ibrutinib Interactions
There are 502 drugs known to interact with ibrutinib, along with 8 disease interactions, and 3 alcohol/food interactions. Of the total drug interactions, 198 are major, 298 are moderate, and 6 are minor.
- View all 502 medications that may interact with ibrutinib
- View ibrutinib alcohol/food interactions (3)
- View ibrutinib disease interactions (8)
Most frequently checked interactions
View interaction reports for ibrutinib and the medicines listed below.
- Activated Charcoal (charcoal)
- Aspir 81 (aspirin)
- Aspirin Low Strength (aspirin)
- Augmentin (amoxicillin / clavulanate)
- Azithromycin Dose Pack (azithromycin)
- Bactrim (sulfamethoxazole / trimethoprim)
- Benadryl (diphenhydramine)
- Claritin (loratadine)
- Crestor (rosuvastatin)
- D3 (cholecalciferol)
- Eliquis (apixaban)
- Flomax (tamsulosin)
- Flonase (fluticasone nasal)
- Glucosamine & Chondroitin with MSM (chondroitin / glucosamine / methylsulfonylmethane)
- Iodides (sodium iodide)
- Lexapro (escitalopram)
- Lomotil (atropine / diphenoxylate)
- Lyrica (pregabalin)
- Metoprolol Succinate ER (metoprolol)
- Metoprolol Tartrate (metoprolol)
- Probiotic Formula (bifidobacterium infantis / lactobacillus acidophilus)
- Rituxan (rituximab)
- Synthroid (levothyroxine)
- Tylenol (acetaminophen)
- Ventolin HFA (albuterol)
- Vitamin B Complex 100 (multivitamin)
- Vitamin B12 (cyanocobalamin)
- Vitamin C (ascorbic acid)
- Vitamin D3 (cholecalciferol)
- Xarelto (rivaroxaban)
Ibrutinib alcohol/food interactions
There are 3 alcohol/food interactions with ibrutinib.
Ibrutinib disease interactions
There are 8 disease interactions with ibrutinib which include:
- arrhythmias
- bleeding
- cytopenia
- hepatic impairment
- hypertension
- infections
- renal impairment
- tumor lysis syndrome
More about ibrutinib
- ibrutinib consumer information
- Compare alternatives
- Reviews (86)
- Side effects
- Dosage information
- Patient tips
- During pregnancy
- Support group
- Drug class: BTK inhibitors
- Breastfeeding
- En español
Related treatment guides
Drug Interaction Classification
Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
No interaction information available. |
See also:
Deltasone
Deltasone is used for acute lymphocytic leukemia, adrenocortical insufficiency, allergic reactions ...
Rituxan
Rituxan infusion is used to treat certain leukemias and lymphomas and some non-cancer conditions ...
Jaypirca
Jaypirca (pirtobrutinib) is a cancer medicine used to treat types of CLL, SLL, and MCL. Includes ...
Kesimpta
Kesimpta (ofatumumab) is used to treat relapsing forms of multiple sclerosis. Includes Kesimpta ...
Jakafi
Jakafi is used to treat certain types of myelofibrosis or polycythemia vera in adults, and certain ...
Imbruvica
Imbruvica (ibrutinib) is used to treat chronic lymphocytic leukemia (CLL), small lymphocytic ...
Venetoclax
Venetoclax (brand name Venclexta) may be used to treat CLL, SLL, or AML in those aged 75 years or ...
Cyclophosphamide
Cyclophosphamide systemic is used for acute lymphocytic leukemia, acute nonlymphocytic leukemia ...
Rituximab
Rituximab infusion is used to treat certain leukemias and lymphomas and some non-cancer conditions ...
Methotrexate
Methotrexate is used to treat certain types of cancer of the breast, skin, head and neck, or lung ...
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.